Virpax Pharmaceuticals, Inc. VRPX
0.00 USD 0.00 (-62.50%)
At closeNov 2, 2026, 4:00 PM EST
0.45 +0.45 +149,833.33%
After hours · Nov 2, 4:00 PM ET
0.021 Day range 0.021
0.0001 52-week range 0.10
- YTD
- -97.30%
- 1 year
- -98.57%
Financial health
Altman Z-Score
-90.71 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.1×
FY 2018 5y median -8.5× FY 2024
P/S 0.0×
FY 2018 5y median 0.0× FY 2024
P/B -44.2×
FY 2018 5y median 11.0× FY 2024
P/FCF -0.0×
FY 2018 5y median -10.2× FY 2024
EV/EBITDA -3.3×
FY 2018 5y median -3.3× FY 2024
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2024
FCF Yield -41351.3%
FY 2018 5y median -9.8% FY 2024
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2024
ROE 1320.6%
FY 2018 5y median -32.4% FY 2024
ROIC 1322.0%
FY 2018 5y median -32.1% FY 2024
ROA -775.7%
FY 2018 5y median -157.8% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2024
Operating Income 23.0%
FY 2018 FY 2024
EPS (diluted) -446.7%
FY 2018 FY 2024
Free Cash Flow -169509.2%
FY 2018 FY 2024
Financial Health
Current Ratio 0.6×
FY 2018 5y median 1.3× FY 2024
Quick Ratio 0.6×
FY 2018 5y median 1.3× FY 2024
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2024
Net Debt / EBITDA 0.1×
FY 2018 5y median 4.1× FY 2024
Interest Coverage -116×
FY 2018 5y median -28.4× FY 2024
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31
